[坦苏洛辛/杜塔斯特的肝毒性:可能病例报告]
1Servicio de Gastroenterología, Hospital Nacional Daniel Alcides Carrión. Lima, Perú.
概括
用于良性前列腺缩的tamsulosin和dutasteride可以导致肝损伤. 一个案例研究表明,一名64岁的男子在联合使用后发展了急性肝炎,在药物停用后得到解决.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 坦素和杜塔斯特是良性前列腺缩 (BPH) 的常见治疗方法.
- 虽然tamsulosin有罕见的肝损伤报告,但dutasteride和联合使用没有记录的肝毒性.
- 这突出了组合治疗的潜在,以前未报告的不良影响.
研究的目的:
- 报告与tamsulosin和dutasteride联合使用相关的肝损伤病例.
- 为了研究这种常见的BPH治疗方案的潜在肝毒性.
主要方法:
- 一个64岁的男性病人的病例报告呈现肝损伤症状.
- 排除其他肝脏病理,包括病毒,自身免疫和代谢原因.
- 诊断成像包括腹部超声波和共振胆血管学.
- 使用CIOMS-RUCAM和Naranjo尺度进行因果关系评估.
主要成果:
- 患者在开始坦苏洛辛/杜塔斯特联合治疗后出现了肝细胞损伤和急性肝炎症状.
- 排除了肝病和胆道病理的其他原因.
- 因果关系评估表明可能 (CIOMS-RUCAM) 和可能 (Naranjo) 药物诱导的肝损伤.
- 停用药物导致临床和实验室的改善.
结论:
- 坦苏洛辛和杜塔斯特联合治疗可能会导致药物诱导性肝损伤 (DILI).
- 这一案例强调了在接受这种联合治疗的患者中监测肝功能的重要性.
- 需要进一步调查tamsulosin/dutasteride的肝毒性.
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
164
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
164
01:20Disorders of the Male Reproductive System
431
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
431
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
708
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
708
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:21Nursing Assessment of the Genitourinary System I: Health History
26
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
26
01:22Heart Failure Drugs: Diuretics
400
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
400